S&P 500   4,569.78 (-0.54%)
DOW   36,204.44 (-0.11%)
QQQ   386.32 (-0.93%)
AAPL   189.43 (-0.95%)
MSFT   369.14 (-1.43%)
META   320.02 (-1.48%)
GOOGL   129.27 (-1.96%)
AMZN   144.84 (-1.49%)
TSLA   235.58 (-1.36%)
NVDA   455.10 (-2.68%)
NIO   7.32 (+2.38%)
BABA   73.03 (-1.30%)
AMD   118.57 (-2.32%)
T   16.66 (-0.60%)
F   10.70 (+1.13%)
MU   74.29 (-2.16%)
CGC   0.76 (+22.36%)
GE   121.53 (-0.79%)
DIS   92.01 (-0.62%)
AMC   7.49 (+9.18%)
PFE   29.28 (+1.28%)
PYPL   59.85 (+0.34%)
XOM   102.43 (-0.54%)
S&P 500   4,569.78 (-0.54%)
DOW   36,204.44 (-0.11%)
QQQ   386.32 (-0.93%)
AAPL   189.43 (-0.95%)
MSFT   369.14 (-1.43%)
META   320.02 (-1.48%)
GOOGL   129.27 (-1.96%)
AMZN   144.84 (-1.49%)
TSLA   235.58 (-1.36%)
NVDA   455.10 (-2.68%)
NIO   7.32 (+2.38%)
BABA   73.03 (-1.30%)
AMD   118.57 (-2.32%)
T   16.66 (-0.60%)
F   10.70 (+1.13%)
MU   74.29 (-2.16%)
CGC   0.76 (+22.36%)
GE   121.53 (-0.79%)
DIS   92.01 (-0.62%)
AMC   7.49 (+9.18%)
PFE   29.28 (+1.28%)
PYPL   59.85 (+0.34%)
XOM   102.43 (-0.54%)
S&P 500   4,569.78 (-0.54%)
DOW   36,204.44 (-0.11%)
QQQ   386.32 (-0.93%)
AAPL   189.43 (-0.95%)
MSFT   369.14 (-1.43%)
META   320.02 (-1.48%)
GOOGL   129.27 (-1.96%)
AMZN   144.84 (-1.49%)
TSLA   235.58 (-1.36%)
NVDA   455.10 (-2.68%)
NIO   7.32 (+2.38%)
BABA   73.03 (-1.30%)
AMD   118.57 (-2.32%)
T   16.66 (-0.60%)
F   10.70 (+1.13%)
MU   74.29 (-2.16%)
CGC   0.76 (+22.36%)
GE   121.53 (-0.79%)
DIS   92.01 (-0.62%)
AMC   7.49 (+9.18%)
PFE   29.28 (+1.28%)
PYPL   59.85 (+0.34%)
XOM   102.43 (-0.54%)
S&P 500   4,569.78 (-0.54%)
DOW   36,204.44 (-0.11%)
QQQ   386.32 (-0.93%)
AAPL   189.43 (-0.95%)
MSFT   369.14 (-1.43%)
META   320.02 (-1.48%)
GOOGL   129.27 (-1.96%)
AMZN   144.84 (-1.49%)
TSLA   235.58 (-1.36%)
NVDA   455.10 (-2.68%)
NIO   7.32 (+2.38%)
BABA   73.03 (-1.30%)
AMD   118.57 (-2.32%)
T   16.66 (-0.60%)
F   10.70 (+1.13%)
MU   74.29 (-2.16%)
CGC   0.76 (+22.36%)
GE   121.53 (-0.79%)
DIS   92.01 (-0.62%)
AMC   7.49 (+9.18%)
PFE   29.28 (+1.28%)
PYPL   59.85 (+0.34%)
XOM   102.43 (-0.54%)

Vitrolife AB (publ) Stock Price, News & Analysis (OTCMKTS:VTRLY)

$13.30
0.00 (0.00%)
(As of 12/1/2023 ET)
Compare
Today's Range
$13.30
$13.30
50-Day Range
$11.45
$13.30
52-Week Range
$11.45
$21.49
Volume
N/A
Average Volume
100 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

VTRLY stock logo

About Vitrolife AB (publ) Stock (OTCMKTS:VTRLY)

Vitrolife AB (publ) engages in development, production, and marketing of products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also offers EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems. It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; Americas; and Asia. The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998. Vitrolife AB (publ) was founded in 1994 and is based in Gothenburg, Sweden.

VTRLY Stock Price History

VTRLY Stock News Headlines

Vitrolife AB
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Election committee for Vitrolife AB (publ)
Vitrolife Group Annual and Sustainability Report 2022
Vitrolife: Conference call interim report
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Conference call interim report: Vitrolife AB (publ)
CEO has purchased shares in Vitrolife AB
See More Headlines
Receive VTRLY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vitrolife AB (publ) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Medical Devices
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:VTRLY
CIK
N/A
Fax
N/A
Employees
1,109
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Ms. Bronwyn Brophy
    Chief Executive Officer
  • Mr. Patrik Tolf (Age 53)
    Chief Financial Officer
  • Mr. Claus Bisgaard (Age 46)
    Senior Vice President of Technologies
  • Mr. Rickard Ericsson (Age 52)
    Senior Vice President of Global Sales & Marketing
  • Guillermo Ferrando (Age 32)
    Vice President Strategy & Corporate development
  • Ms. Karin Koritz Russberg (Age 54)
    Senior Vice President of HR & Sustainability
  • Ricardo Capella (Age 55)
    Senior Vice President Genetic Services














VTRLY Stock Analysis - Frequently Asked Questions

Should I buy or sell Vitrolife AB (publ) stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Vitrolife AB (publ) in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" VTRLY shares.
View VTRLY analyst ratings
or view top-rated stocks.

How have VTRLY shares performed in 2023?

Vitrolife AB (publ)'s stock was trading at $11.93 at the beginning of 2023. Since then, VTRLY stock has increased by 11.5% and is now trading at $13.30.
View the best growth stocks for 2023 here
.

How do I buy shares of Vitrolife AB (publ)?

Shares of VTRLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:VTRLY) was last updated on 12/4/2023 by MarketBeat.com Staff

My Account -